Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate (Q84552532)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 14, 2011

Language	Label	Description	Also known as
English	Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate	scientific article published on July 14, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate (English)

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

7

object named as

Ruth Arnon

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

1

object named as

Rina Aharoni

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Anya Vainshtein

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Ariel Stock

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Raya Eilam

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Renana From

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Vera Shinder

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21752599

7 December 2024

publication date

14 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0896841111000692?httpAccept=text/xml

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

https://api.elsevier.com/content/article/PII:S0896841111000692?httpAccept=text/plain

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Journal of Autoimmunity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

228-241

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

The immunopathology of multiple sclerosis: an overview

1

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Mechanisms of inflammation induced tissue injury in multiple sclerosis

2

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

The immunology of multiple sclerosis: disease mechanisms and therapeutic targets

3

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Immunopathogenesis and immunotherapy of multiple sclerosis

4

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

5

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Multiple sclerosis: an immune or neurodegenerative disorder?

6

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Neurodegeneration in autoimmune CNS inflammation

8

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Grey matter pathology in multiple sclerosis

9

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Animal models of multiple sclerosis

10

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine

11

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis

12

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.

13

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments

14

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

15

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss

16

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Spinal motoneurone distress during experimental allergic encephalomyelitis.

17

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Linkage between immunomodulation, neuroprotection and neurogenesis

18

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Remyelination in multiple sclerosis

19

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS

20

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice

21

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Immunomodulatory drug treatment in multiple sclerosis

22

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

23

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

24

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

25

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

26

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

27

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

28

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

29

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

30

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factorin situ

31

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis

32

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.

33

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice

34

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate

35

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.

36

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

37

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP

38

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Differential expression of calcitonin gene-related peptide (CGRP) and choline acetyltransferase (ChAT) in the axotomized motoneurons of normoxic and hypoxic rats.

39

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

GFAP in health and disease.

40

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Markers for neuronal degeneration in organotypic slice cultures

41

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis

42

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.

43

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man

44

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

miRNA malfunction causes spinal motor neuron disease

45

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

46

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Neurotrophin secretion: current facts and future prospects

47

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

48

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

TGF-?-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway

50

1 reference

10.1016/J.JAUT.2011.06.003

https://api.crossref.org/works/10.1016/J.JAUT.2011.06.003

7 December 2024

Identifiers

10.1016/J.JAUT.2011.06.003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21752599 AND SRC:MED&resulttype=core&format=json

7 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84552532&oldid=2284279744"